Hologic takes hit in fourth quarter
Hologic has experienced a financially challenging year, due in part to its acquisition of Direct Radiography Corp., and in part to a soft market for bone densitometry. The Bedford, MA, company posted sharply lower fiscal 1999 (end-September) results this
Hologic has experienced a financially challenging year, due in part to its acquisition of Direct Radiography Corp., and in part to a soft market for bone densitometry. The Bedford, MA, company posted sharply lower fiscal 1999 (end-September) results this month, reporting revenues of $84.1 million as compared with $115.6 million in 1998, and a net loss of $3.7 million as compared with net income of $10.4 million the previous year. In its fourth quarter the company saw revenues of $20.1 million, compared with $24.8 million in 1998, and sustained a net loss of $3.2 million, compared with net income of $1.3 million. Without the acquisition of DRC, which was finalized in June (SCAN 6/23/99), Hologics net losses would have totaled $315,000 for the fourth quarter and would have been negligible for the fiscal year.
Sales in Hologics bone densitometry business were less brisk than the company had hoped, particularly in the U.S. primary care market. Hologic saw decreased demand for its DXA systems, and slower sales of its Sahara ultrasound bone sonometer. In an effort to boost its business, Hologic has bulked up its direct sales team and increased its physician education activities, as well as moving to streamline its U.S. operations, the company said.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Meta-Analysis Shows Merits of AI with CTA Detection of Coronary Artery Stenosis and Calcified Plaque
April 16th 2025Artificial intelligence demonstrated higher AUC, sensitivity, and specificity than radiologists for detecting coronary artery stenosis > 50 percent on computed tomography angiography (CTA), according to a new 17-study meta-analysis.
New bpMRI Study Suggests AI Offers Comparable Results to Radiologists for PCa Detection
April 15th 2025Demonstrating no significant difference with radiologist detection of clinically significant prostate cancer (csPCa), a biparametric MRI-based AI model provided an 88.4 percent sensitivity rate in a recent study.
